Development and Presentation Faculty
Kori Dewing, DNP, ARNP
Virginia Mason Medical Center
University of Washington School of Nursing
Department of Biobehavioral Nursing and Health Systems
Additional Development Faculty
Susan Simmons PhD, ARNP, FNP-BC
Family Nurse Practitioner
Olathe Medical Services
Sophia L. Thomas APRN, FNP-BC
Family Nurse Practitioner,
St. Charles Community Health Center
1.0 contact hour of continuing education (which includes 0.25 hours of pharmacology)
THIS PROGRAM WAS ORIGINALLY PRESENTED AS AN AANP LIVE GROUP LECTURE SERIES (GLS) BEGINNING OCTOBER 19, 2011. IF YOU RECEIVED CREDIT FOR PARTICIPATING IN THE GLS, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE ACTIVITY.
Approximately 1.3 million people in the United States have rheumatoid arthritis (RA). RA is a systemic chronic inflammatory disease that causes joint pain, stiffness, and swelling—and it increases the risk and complications of comorbidities such as cardiovascular disease and early mortality. Without appropriate treatment, RA progresses and causes joint deformity leading to significant loss of function.
Given the new clinical evidence, nurse practitioners have the opportunity to improve outcomes in patients with RA by expanding their skills in the management of RA when patient access to the rheumatology provider is limited or delayed. In doing so, they can ensure an accurate early diagnosis of RA, and initiate treatment early and optimally with a disease-modifying antirheumatic drug (DMARD). This continuing education activity seeks to expand the ability of nurse practitioners to implement best practices in the management of RA based on the latest clinical evidence, ultimately improving function and enhancing quality of life while contributing to mortality reduction in patients with RA.
Developed by the American Association of Nurse Practitioners in cooperation with
MCM Education Target Audience
This program was developed for nurse practitioners.
Upon completion of this educational activity, the participant should be able to:
Explain the classification criteria for rheumatoid arthritis.
Summarize the current evidence-based guideline recommendations regarding use of nonbiologic and biologic DMARDS.
Develop a treatment plan based on the most current evidence and guideline recommendations for patients with early rheumatoid arthritis to suppress disease activity and prevent joint destruction and related complications.
Outline strategies to improve appropriate and timely referral to rheumatology.
Kori Dewing, DNP, ARNP has no conflicts of interest to disclose.
Susan Simmons PhD, ARNP, FNP-BC has no conflicts of interest to disclose.
Sophia L. Thomas APRN, FNP-BC has no conflicts of interest to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Credit Statements
This program is approved for 1.0 contact hour of continuing education (which includes 0.25 hours of pharmacology) by the American Association of Nurse Practitioners. Program ID 1206236.
This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
Commercial Support Statements
This activity is supported through educational grants from Abbott Laboratories and Pfizer Inc.
COMPLETING THE POST TEST AND EVALUATION:
When you return to the AANP CE Center, login and find the program you wish to complete. On the program’s content page you can go directly to Start Post-Test at the bottom of the page. When you have successfully completed the online post-test you will be instructed to complete the online evaluation and then receive your certificate.
If you do not have a registration (email and password) with AANP, you will be asked to register: MyAANP. Complete the short profile and create your password to continue in the CE Center. Please contact Stormy Causey, CE Coordinator, at CECenter@aanp.org with any questions.
The opinions expressed in this presentation are those of the speaker and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the American Academy of Nurse Practitioners, Abbott Laboratories, or Pfizer Inc.